Curemark secures $6.5 million in funding
-
- August
- 10
Curemark, a Rye-based drug research and development company, said that it has secured $6.5 million of initial funding from private investors. The privately held company said that the financing will allow it to conduct clinical trials on an autism treatment at 11 sites across the country.
This entry was posted
on Monday, August 10th, 2009 at 12:36 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical
Print
|
Email
Leave a Reply
It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the
Terms of Service.